IGM Biosciences, Inc.

NasdaqGS:IGMS 주식 보고서

시가총액: US$405.5m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

IGM Biosciences 관리

관리 기준 확인 3/4

IGM Biosciences' CEO는 Fred Schwarzer, Jul2010 에 임명되었습니다 의 임기는 13.92 년입니다. 총 연간 보상은 $ 3.21M, 20.2% 로 구성됩니다. 20.2% 급여 및 79.8% 보너스(회사 주식 및 옵션 포함). 는 $ 1.74M 가치에 해당하는 회사 주식의 0.41% 직접 소유합니다. 1.74M. 경영진과 이사회의 평균 재임 기간은 각각 3.2 년과 5.8 년입니다.

주요 정보

Fred Schwarzer

최고 경영자

US$3.2m

총 보상

CEO 급여 비율20.2%
CEO 임기13.9yrs
CEO 소유권0.4%
경영진 평균 재임 기간3.2yrs
이사회 평균 재임 기간5.8yrs

최근 관리 업데이트

Recent updates

IGM Biosciences: Unlikely To Move The Needle Again In 2024

May 12

Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Invest In Growth?

Apr 28
Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Invest In Growth?

IGM Biosciences: Imvotamab Data 2nd Half Of 2024 With Other Inflection Points

Feb 12

We Think IGM Biosciences (NASDAQ:IGMS) Needs To Drive Business Growth Carefully

Nov 20
We Think IGM Biosciences (NASDAQ:IGMS) Needs To Drive Business Growth Carefully

We're Not Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn

May 10
We're Not Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn

Here's Why We're Not At All Concerned With IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation

Jan 05
Here's Why We're Not At All Concerned With IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation

IGM Biosciences (NASDAQ:IGMS) Is In A Strong Position To Grow Its Business

Sep 23
IGM Biosciences (NASDAQ:IGMS) Is In A Strong Position To Grow Its Business

IGM Biosciences started at BofA Securities with a buy on IgM antibody candidates

Aug 29

IGM Biosciences GAAP EPS of -$1.33 misses by $0.93, revenue of $0.4M

Aug 08

We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate

Jun 09
We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate

IGM Biosciences: Interesting Science, Poor Trial Data

Feb 23

Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Deliver On Growth Plans?

Feb 17
Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not Too Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation

Sep 07
Here's Why We're Not Too Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation

IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans

May 25
IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans

IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans

Feb 08
IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans

IGM Biosciences reports quick assets and provides business updates

Jan 13

Trade Alert: The Independent Director Of IGM Biosciences, Inc. (NASDAQ:IGMS), M. Behrens, Has Just Spent US$4.0m Buying 39% More Shares

Dec 18
Trade Alert: The Independent Director Of IGM Biosciences, Inc. (NASDAQ:IGMS), M. Behrens, Has Just Spent US$4.0m Buying 39% More Shares

IGM Bio prices upsized $200M public offering

Dec 09

IGM Biosciences proposes public offering

Dec 07

IGM Biosciences (IGMS) Investor Presentation - Slideshow

Nov 20

CEO 보상 분석

Fred Schwarzer 의 보수는 IGM Biosciences 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$237m

Dec 31 2023US$3mUS$647k

-US$246m

Sep 30 2023n/an/a

-US$238m

Jun 30 2023n/an/a

-US$234m

Mar 31 2023n/an/a

-US$229m

Dec 31 2022US$5mUS$622k

-US$221m

Sep 30 2022n/an/a

-US$219m

Jun 30 2022n/an/a

-US$205m

Mar 31 2022n/an/a

-US$185m

Dec 31 2021US$10mUS$598k

-US$165m

Sep 30 2021n/an/a

-US$139m

Jun 30 2021n/an/a

-US$115m

Mar 31 2021n/an/a

-US$95m

Dec 31 2020US$5mUS$530k

-US$81m

Sep 30 2020n/an/a

-US$72m

Jun 30 2020n/an/a

-US$61m

Mar 31 2020n/an/a

-US$53m

Dec 31 2019US$757kUS$428k

-US$43m

Sep 30 2019n/an/a

-US$37m

Jun 30 2019n/an/a

-US$34m

Mar 31 2019n/an/a

-US$27m

Dec 31 2018US$519kUS$376k

-US$23m

보상 대 시장: Fred 의 총 보상 ($USD 3.21M )은 US 시장( $USD 2.43M ).

보상과 수익: Fred 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Fred Schwarzer (71 yo)

13.9yrs

테뉴어

US$3,207,328

보상

Mr. Fred M. Schwarzer, J.D., was a Founder of Charter Life Sciences, a venture capital firm specializing in life sciences investments, in 2003 and served as its Managing Partner from inception until August...

리더십 팀

이름위치테뉴어보상소유권
Fred Schwarzer
CEO, President & Director13.9yrsUS$3.21m0.42%
$ 1.7m
Bruce Keyt
Chief Scientific Officer11.8yrsUS$1.57m0.18%
$ 745.3k
Chris Takimoto
Chief Medical Officer2.9yrsUS$1.56m0.045%
$ 182.2k
Misbah Tahir
Chief Financial Officer5.4yrsUS$1.08m0.028%
$ 114.5k
TS Harigopal
Senior Vice President of Group Operations1.4yrs데이터 없음데이터 없음
Steven Weber
Senior VP2.3yrs데이터 없음0.0032%
$ 12.9k
Paul Graffagnino
Senior Vice President of Legal Affairs3.4yrs데이터 없음데이터 없음
Suzette Tauber
Chief Human Resources Officer5yrs데이터 없음데이터 없음
Angus Sinclair
Senior Vice President of Immuno-Oncology2.8yrs데이터 없음데이터 없음
Lisa Decker
Chief Business Officer3.3yrsUS$4.92m0.029%
$ 117.8k
Marvin Peterson
Executive Vice President of Process Development & Manufacturing3.2yrs데이터 없음데이터 없음
Mary Harler
Head of Research & Autoimmunity2.7yrs데이터 없음0.14%
$ 585.5k

3.2yrs

평균 재임 기간

59.5yo

평균 연령

경험이 풍부한 관리: IGMS 의 관리팀은 경험 ( 3.2 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Fred Schwarzer
CEO, President & Director21.3yrsUS$3.21m0.42%
$ 1.7m
Felix Baker
Independent Director3.4yrsUS$168.55k0%
$ 0
M. Behrens
Independent Director5.4yrsUS$178.30k0.68%
$ 2.8m
Mark Davis
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Rafi Ahmed
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Michael Lee
Independent Director4.9yrsUS$166.09k0.0099%
$ 40.2k
Jakob Topsoe
Independent Director5.8yrsUS$166.09k0.14%
$ 582.9k
Julie Hambleton
Independent Director5.8yrsUS$204.09k0.0034%
$ 13.7k
Christina Topsoe
Independent Director5.8yrsUS$175.84k0.090%
$ 366.9k
William Strohl
Independent Director5.8yrsUS$236.59k0%
$ 0
Elizabeth Thompson
Independent Directorless than a yearUS$167.54k0.0025%
$ 10.0k
Gordon J. Freeman
Member of Scientific Advisory Boardno data데이터 없음데이터 없음

5.8yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 이사회: IGMS 의 이사회는 경험(평균 재직 기간 5.8 년)으로 간주됩니다.